Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 24, 2022

Primary Completion Date

May 24, 2026

Study Completion Date

May 15, 2031

Conditions
MINOCAAtrial Fibrillation
Interventions
DEVICE

CONFIRM Rx implantable cardiac rhythm monitor (Abbott)

Implantation of CONFIRM Rx ICM

DIAGNOSTIC_TEST

Systematic etiologic work-up for underlying causes of MINOCA

Intracoronary optical coherence tomography, cardiac magnetic resonance imaging, transesophageal echocardiography, vasospasm testing, thrombophilia screening, Holter ECG (only non-ICM group)

Trial Locations (2)

3010

RECRUITING

Bern University Hospital Inselspital, Bern

8091

RECRUITING

University Hospital Zurich USZ, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University Hospital, Zürich

OTHER

collaborator

Bangerter-Rhyner Stiftung

UNKNOWN

collaborator

Abbott

INDUSTRY

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT05326828 - Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA | Biotech Hunter | Biotech Hunter